G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020

Ads

You May Also Like

Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors

SAN CARLOS, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology ...

argenx reports third quarter 2018 financial results and provides business update

October 25, 2018Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), ...